Pure Health Peptides 5-Amino-1MQ 50mg – 60 Capsules

Pure Health Peptides 5-Amino-1MQ is an encapsulated synthetic small-molecule material supplied exclusively for controlled in-vitro laboratory research. Despite being sold by a research-peptide company, 5-Amino-1MQ is not a peptide because it does not contain an amino-acid chain and is manufactured through chemical synthesis. This 60-capsule format provides a stated 50 mg of research compound per capsule to support controlled containment, inventory organization and analytical handling. The capsules do not represent an oral dosage form or imply any route of administration, and the product must not be presented or used as a drug, dietary supplement, weight-management product, food, cosmetic or veterinary preparation.

The Science of 5-Amino-1MQ Research Optimization

5-Amino-1MQ, or 5-amino-1-methylquinolinium, is a quinolinium-derived small molecule investigated primarily for its interaction with nicotinamide N-methyltransferase, commonly abbreviated as NNMT. Published work remains preclinical and includes biochemical assays, cultured-cell systems and animal models rather than established human applications. NNMT Enzyme Interaction: Experimental research has evaluated 5-Amino-1MQ as a selective and cell-permeable inhibitor of NNMT. In controlled assays, researchers use the molecule to examine how reduced NNMT activity changes enzymatic output and downstream cellular behavior. Nicotinamide Pathway Context: NNMT transfers a methyl group to nicotinamide and participates in pathways connected with methyl-donor utilization and NAD-associated metabolism. Inhibiting this enzyme provides a research tool for evaluating pathway-level changes under predefined laboratory conditions. Preclinical Metabolic Models: Cell and animal research has investigated NNMT inhibition in relation to adipocyte biology, cellular energy expenditure and metabolic signaling. These observations do not demonstrate weight loss, safety, effectiveness or an appropriate dose in humans. Review the foundational preclinical research concerning selective small-molecule NNMT inhibitors.

Key Research Features of Pure Health Peptides 5-Amino-1MQ

Specifications

Research Handling Guide

This material should be received, inventoried and handled only by qualified laboratory personnel working under a documented in-vitro research protocol. Before beginning an experiment, review the lot-specific Certificate of Analysis, compound identity, assay results, capsule content verification, safety documentation and institutional handling requirements. Store the container tightly sealed in a cool, dry environment away from light and moisture. Researchers should use suitable personal protective equipment, calibrated equipment, validated analytical procedures and appropriate negative and positive controls. The encapsulated format must not be interpreted as a human dose or route of administration.

Safety Information

5-Amino-1MQ is an experimental small molecule with no established human dosage, clinical safety profile or approved consumer use. Do not swallow, administer, inhale or apply the capsule contents to humans or animals. Pure Health Peptides states that the product is for qualified in-vitro research only and has not been evaluated by FDA as a drug, food, cosmetic or dietary supplement. FDA has also stated that compounded drug products using 5-Amino-1MQ were not eligible for section 503B exemptions because the substance was not on the applicable bulk-drug list. Follow institutional procedures for exposure control, spills, waste disposal, secure storage and unauthorized-access prevention.

Frequently Asked Questions

Is 5-Amino-1MQ a peptide? Why is the research material supplied in capsules? What is 5-Amino-1MQ studied for? Does 50 mg represent a recommended human dose?